Skip to content

Comparison of levofloxacin versus clarithromycin efficacytherapy for helicobacter pylori eradication

Comparison of levofloxacin versus clarithromycin efficacy in bismuth-containing quadruple therapy for helicobacter pylori eradication

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190606043826N1
Enrollment
194
Registered
2019-06-24
Start date
2019-06-05
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters

Interventions

Intervention 1: The intervention group was as follows treated with 4 doses of bismuth substrate (2 tablets every 12 hours), omeprazole (20 mg every 12 hours),amoxicillin (1 g every 12 hours) Clarith

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 70 Years

Inclusion criteria

Inclusion criteria: Positive h.pylori people have indications of treatment Age between 14 and 70 years Patients with informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Do not use the correct and regular drug Incidence of unbearable side effects Pregnancy and lactation The presence of chronic liver, kidney and gastrointestinal diseases simultaneously Previous history of h.pylori treatment in a recent month

Design outcomes

Primary

MeasureTime frame
The presence or absence of stool antigen,. Timepoint: At the end of the first and second weeks of treatment. Method of measurement: Fecal antigen test to confirm eradication of infection.;Incidence or absence of drug side effects. Timepoint: At the end of the first and second weeks of treatment. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Arj

Kashan University of Medical Sciences

Dr_Arj@yahoo.com+98 31 5550 0111

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026